Symbol="NBSE"
AssetType="Common Stock"
Name="NeuBase Therapeutics Inc"
Description="NeuBase Therapeutics, Inc., a preclinical biopharmaceutical company, focuses on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1173281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="1946100"
EBITDA="-23408468"
PERatio="None"
PEGRatio="None"
BookValue="5.99"
DividendPerShare="0"
DividendYield="0"
EPS="-17.41"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.43"
ReturnOnEquityTTM="-0.935"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-17.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="140"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.224"
EVToRevenue="-"
EVToEBITDA="0.524"
Beta="0.619"
num_52WeekHigh="14.61"
num_52WeekLow="0.605"
num_50DayMovingAverage="1.522"
num_200DayMovingAverage="3.479"
SharesOutstanding="2362400"
DividendDate="2019-02-04"
ExDividendDate="None"
symbol="NBSE"
open="0.78"
high="0.87"
low="0.75"
price="0.76"
volume="174839.00"
latest_trading_day="2023-08-28"
previous_close="0.82"
change="-0.06"
change_percent="-7.6232%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="415950"
Change_recent_avg="-0.03"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.71"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="500"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="686"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_positive_thumbnail_id_2="1002"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
